Carbon Disulfide

Total Page:16

File Type:pdf, Size:1020Kb

Carbon Disulfide This report contains the collective views of an inter- national group of experts and does not necessarily represent the decisions or the stated policy of either the World Health Organization or the United Nations Environment Programme. Environmental Health Criteria 10 CARBON DISULFIDE Published under the joint sponsorship of the United Nations Environment Programme and the World Health Organization I - - V b: IQ\_- - Vkl l World Health Organization Geneva, 1979 ISBN 924 1540702 © World Health Organization 1979 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. For rights of reproduction or translation of WHO publications, in part or in toto, application should be made to the Office of Publications, World Health Organization, Geneva, Switzerland. The World Health Organization welcomes such applications. The designations employed and the presentation of the material in this publication do rrot imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. S The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. PRiNTED IN THE UNITED KINGDOM CONTENTS Page ENVIRONMENTAL HEALTH CRITERIA FOR CARBON DISULFIDE - . 9 I. SUMMARY AND RECOMMENDATIONS FOR FURTHER RESEARCH . Ii 1.1 Summary .......................... It 1.1.1 Uses and sources of exposure ................ II 1.1.2 Populations at risk .................... II 1.1.3 Estimation of exposure .................. II 1.1.4 Metabolism ...................... [ 2 1.1.5 Mechanisms of toxic action ................ 13 1.1.6 Carbon disulfide poisoning; evaluation of the health risk to man . 13 1.1.7 Diagnosis of carbon disutfide poisoning ............ 15 1.1.8 Surveillance of exposed workers ............... 15 1.2 Recommendations for further research ............... 16 1.2.1 Analytical aspects .................... 16 1.2.2 Studies on health effects .................. 16 1.2.3 Mechanisms of toxic action ................ 16 2. PROPERTIES AND ANALYTICAL METHODS ............17 2.1 Chemical and physical properties .................17 2.2 Analytical procedures ..................... 17 2.2.1 Measurement of carbon disulfide in air ............ 17 2.2.2 Sampling methods .................... IS 2.2.2.1 The activated charcoal tube method .......... 18 2.2.2.2 The liquid absorption method ............ 18 2.23 Methods for the determination of carbon disulfide ........ 19 2.2.3.1 Direct measurement using gas detector tubes ...... 19 2.2.3.2 Photometric determination ............. 19 2.2.3.3 Gas—liquid chromatographic determination ....... 19 2.2.3.4 Continuous measurement using gas analysers ...... 20 2.2.3.5 Determination of metabolites in urine ......... 20 3. EXPOSURE TO CARBON DISULFIDE ............... 22 3.1 Occupational exposure ..................... 22 3.2 Community exposure ..................... 22 4. METABOLISM .........................24 4.1 Absorption .........................24 4.1.1 Inhalation .......................24 4.1.2 Skin absorption .....................25 4.2 Distribution and biotransformation ................25 4.2.1 Balance of absorbed carbon disulfide .............25 4.2.2 Transport by the bloodstream ...............26 4.2.3 Determination of carbon disulfide in blood ...........26 4.2.4 Distribution in the organism ................26 4.2.5 Binding in blood and tissues ................28 4.3 Elimination of carbon disulfide and metabolites ............28 4.3.1 Elimination by breath, saliva, sweat, and faeces .........28 4.3.2 Excretion of carbon disulfide and metabolites in urine .......29 3 5. BIOCHEMICAL EFFECTS OF CARBON DISULFIDE 32 5.1 Chelating effects of carbon disulfide metaholitcs ............ 33 5.2 Effects on enzyme systems .................... 5.3 Effects on vitamin metabolism .................. 36 5.3.1 Vitamin B........................16 5.3.2 Nicotinic acid ..................... 38 5.4 Effects on catecholaminc metabolism ................ 38 S 5.5 Effects on lipid metabolism ................... 38 5.6 Interaction with microsomal drug metabolism ............ 39 6. CARBON DISULFtDE POISONING ................. 41 6. t Historical review ....................... 41 6.2 Clinical picture of carbon disulfide poisoning ............. 42 6.3 Effects on organ systems .................... 43 6.3.1 Dermatological effects .................. 43 6.3.2 Ophthalmological effects ................. 43 6.3.3 Otnlogical effects .................... 45 6.3.4 Respiratory effects .................... 46 6.3.5 Gastrointestinal effects .................. 46 6.3.6 Hepatic effects ..................... 46 6.3.7 Renal effects ...................... 48 6.3.8 Haematological effects .................. 48 6.3.9 The endncrine system .................. 49 6.3.10 Effects on the nervous system ................ SI 6.3.10.1 Central nervous system ............. SI 6.3,10,2 Peripheral nervous system ............ 56 6.3.11 Cardiovasctslareffects .................. 59 ' 6.3.12 Carcinogenicity and mutagenicit .............. 62 6.3.13 Teratogenic effects ................... 62 6.3.14 Other effects ...................... 62 6.3.15 Interactions with other chemical compounds .......... 63 6.4 Diagnosis .......................... 64 6.5 Surveillance of the health of exposed workers ............. 66 6.6 Contraindications for exposure to carbon disulfide ........... 68 7. EXPOSURE-EFFECT AND EXPOSURE-RESPONSE RELATIONSHIPS . . 69 7.1 Validity of exposure data .................... 69 7.2 Experimental data ....................... 69 7.2.1 Acute animal exposure .................. 69 7.2.2 Long-term animal exposure ................ 69 7.3 Epidemiological data ...................... 70 7.3.1 Neurological and behavioural effects ............. 70 7.3.2 Cardiovascular effects .................. 71 7.3.3 Ophthalmological effects ................. 72 7.3.4 Gonadal effects ..................... 73 - 8. CONTROL OF EXPOSURE IN THE VISCOSE INDUSTRY ........ 74 REFERENCES ........................... 77 ANNEX t Production of viscose and its end-products ............ 95 ANNEX II Maximum permissible concentrations for carbon disulfide in different countries ........................ 99 4 NOTE TO READERS OF THE CRITERIA DOCUMENTS While every effort has been made to present information in the criteria documents as accurately as possible without unduly delaying their publication, mistakes might have occurred and are likely to occur in the - future. In the interest of all users of the environmental health criteria documents, readers are kindly requested to communicate any errors found to the Division of Environmental Health, World Health Organization, Geneva, Switzerland, in order that they may be included in corrigenda which will appear in subsequent volumes. In addition, experts in any particular field dealt with in the criteria documents are kindly requested to make available to the WHO Secretariat any important published information that may have inadvertently been omitted and which may change the evaluation of health risks from exposure to the environmental agent under examination, so that the infor- mation may be considered in the event of updating and re-evaluation of the conclusions contained in the criteria documents. WHO TASK GROUP ON ENVIRONMENTAL HEALTH CRITERIA FOR CARBON DISULFIDE Participants - Members Or G. Avilova, Institute of Hygiene and Preventive Medicine, Academy of Medical Sciences. Moscow, USSR Dr A. Cavalleri. Institute of Occupational Medicine. University of Pavia. Pavia, Italy Or D. Djuriê, Institute of Occupational and Radiological Health. Belgrade, Yugoslavia Professor K. J. Freundt. Institute of Pharmacology and Toxicology. Faculty of Clinical Medicine, Mannheim, Federal Republic of Germany Dr S. Hernberg, tnstitute of Occupational Health, Helsinki, Finland Dr F. Luki, Institute of Hygiene and Epidemiology, Centre of Industrial Hygiene and Occupational Diseases, Prague, Czechoslovakia Professor A. A. F. Massoud, Department of Preventive and Industrial Medicine. Fin Shams University, Cairo, Egypt Professor W. 0. Phoon. Department of Social Medicine and Public Health. Faculty of Medicine, University of Singapore. Singapore Mr V. Rose, National Institute for Occupational Safety and Health. Rockville, MD, USA Or S. Tarkowski. Department of Biochemistry. Institute of Occupational Medicine, Lodz, Poland Professor J. Teisinger. Institute of Hygiene and Epidemiology, Prague, Czechoslovakia (Chairman) .. Dr H. Thiele, Central Institute for Occupational Medicine, Berlin, German Democratic Republic Professor S. Yamaguchi, Department of Public Health. Isukuba University, School of Medicine, Niihari-Gun, Ibaraki ken, Japan Professor S. H. Zaidi, Industrial Toxicology Research Centre. Lucknnw. tndia Secretariat Dr. A. David. tnstitute of Hygiene and Epidemiology. Centre of tndustrial Hygiene and Occupational Diseases. Prague, Czechoslovakia (Notional Coordinotor and Co-Chairman) Dr M. A. El Batawi, Chief Medical Officer, Office of Occupational Health, World Health Organization, Geneva, Switzerland (Secretor;) ENVIRONMENTAL HEALTH CRITERIA
Recommended publications
  • Chemistry Department 32.Pdf (10.36Mb)
    THE FABRICATION OF NANOMETRIC METAL SULFIDES FROM XANTHATE PRECURSORS By ALAN PIQUETTE Bachelor of Arts Western State College of Colorado Gunnison, Colorado 2002 Submitted to the Faculty of the Graduate College of the Oklahoma State University In partial fulfillment of The requirements for The Degree of DOCTOR OF PHILOSOPHY December, 2007 THE FABRICATION OF NANOMETRIC METAL SULFIDES FROM XANTHATE PRECURSORS Thesis Approved: _______________ __Allen Apblett___ ______________ Thesis Advisor ________________ Nicholas Materer_____ __________ _____________ __LeGrande Slaughter___ __________ _______________ ____Jim Smay___ _______________ _____________ __A. Gordon Emslie___ ____________ Dean of the Graduate College ACKNOWLEDGEMENTS It is with my utmost sincere appreciation that I acknowledge my thesis advisor, Dr. Allen W. Apblett, for his support, guidance, and motivation. He provided a research environment that was both friendly and challenging, which made my years in his group enjoyable and rewarding. His broad range of knowledge was something of which I was happy to take advantage. His dedication to teaching and research is something that will be a positive influence on me for the rest of my scientific career. I would like to express gratitude to my committee members: Dr. Nicholas Materer, Dr. LeGrande Slaughter, and Dr. Jim Smay, for their assistance, advice, guidance, and support throughout the years. I am deeply grateful to all my colleagues and friends in the chemistry department. I would specifically like to thank Sulaiman Al-Fadul, Mohammed Al-Hazmi, Zeid Al- Othmann, Mohamed Chehbouni, Satish Kuriyavar, and Tarek Trad for showing me the ropes, for their valuable discussions, continuous encouragement, and for all the help they extended during the course of my stay in the Apblett Group.
    [Show full text]
  • Metabotropic Glutamate Receptors
    mGluR Metabotropic glutamate receptors mGluR (metabotropic glutamate receptor) is a type of glutamate receptor that are active through an indirect metabotropic process. They are members of thegroup C family of G-protein-coupled receptors, or GPCRs. Like all glutamate receptors, mGluRs bind with glutamate, an amino acid that functions as an excitatoryneurotransmitter. The mGluRs perform a variety of functions in the central and peripheral nervous systems: mGluRs are involved in learning, memory, anxiety, and the perception of pain. mGluRs are found in pre- and postsynaptic neurons in synapses of the hippocampus, cerebellum, and the cerebral cortex, as well as other parts of the brain and in peripheral tissues. Eight different types of mGluRs, labeled mGluR1 to mGluR8, are divided into groups I, II, and III. Receptor types are grouped based on receptor structure and physiological activity. www.MedChemExpress.com 1 mGluR Agonists, Antagonists, Inhibitors, Modulators & Activators (-)-Camphoric acid (1R,2S)-VU0155041 Cat. No.: HY-122808 Cat. No.: HY-14417A (-)-Camphoric acid is the less active enantiomer (1R,2S)-VU0155041, Cis regioisomer of VU0155041, is of Camphoric acid. Camphoric acid stimulates a partial mGluR4 agonist with an EC50 of 2.35 osteoblast differentiation and induces μM. glutamate receptor expression. Camphoric acid also significantly induced the activation of NF-κB and AP-1. Purity: ≥98.0% Purity: ≥98.0% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10 mM × 1 mL, 100 mg Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg (2R,4R)-APDC (R)-ADX-47273 Cat. No.: HY-102091 Cat. No.: HY-13058B (2R,4R)-APDC is a selective group II metabotropic (R)-ADX-47273 is a potent mGluR5 positive glutamate receptors (mGluRs) agonist.
    [Show full text]
  • United States Patent (113,607,865
    United States Patent (113,607,865 (72) Inventors John Dyer (56) References Cited Media; UNITED STATES PATENTS Lyle H. Phifer, West Chester, both of Pa. 2,694,723 l l 11954 Schramm ..................... 260/455 B 2l Appl. No. 732,551 2,761,247 9/1956 Meadows.... a 260/216 22 Filed May 28, 1968 2,825,655 3/1958 Meadows..................... 260/216 45) Patented Sept. 21, 1971 2,910,466 101959 Watt............................. 260/216 73) Assignee FMC Corporation Philadelphia, Pa. 3.141023,103,507 9/19637/1964 O'Boyle...Knoevenagel. 260/234 Primary Examiner-Lewis Gotts (54) PREPARATION OFXANTHATES Assistant Examiner-Johnnie R. Brown 10 Claims, No Drawings Attorneys-Thomas R. O'Malley, George F. Mueller and Robert G. Hoffmann 52) U.S.C........................................................ 260/234 R, 260/26, 260/455 B 51 int. Cl......................................................... C07c69132 ABSTRACT: A method of forming alcohol xanthates utilizing 50 Field of Search............................................ 260/455 B, a transXanthation reaction between an alcohol xanthate and 234,216 an alcohol, is disclosed herein. 3,607,865 PREPARATION OFXANTHATES erythritol Alcohol xanthic acids and their derivatives are known to be sorbital useful for a variety of applications including mineral flotation glucose agents, sulfidizing agents, rubber vulcanization accelerators, mannitol adhesives and as intermediates in the preparation of shaped 2-methoxyethanol articles, for example, regenerated cellulose fibers and films. 2-ethoxyethanol In general, alcohol xanthates have been derived by reacting 2-butoxyethanol carbon disulfide with simple and complex alcohols under al diethyleneglycol ethylether kaline conditions. Reactions of this type have been known for polyethylene glycols many years and may be seen, for example, in many prior U.S.
    [Show full text]
  • An Improved Method for BTEX Extraction From
    Analytical Methods Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/methods Page 1 of 6 Analytical Methods 1 2 Analytical Methods RSC Publishing 3 4 5 TECHNICAL NOTE 6 7 8 9 An improved method for BTEX extraction from 10 charcoal 11 Cite this: DOI: 10.1039/x0xx00000x 12 13 Raffaele Cucciniello a, Antonio Proto a,*, Federico Rossi a, Nadia 14 b c 15 Marchettini , Oriana Motta Received 00th January 2015, 16 Accepted 00th January 2015 17 Abstract In this paper we propose a simple procedure for the extraction of BTEX (benzene, 18 DOI: 10.1039/x0xx00000x toluene, ethylbenzene and xylenes) from activated charcoal. For this purpose synthetic samples 19 www.rsc.org/ were prepared in laboratory and real samples were collected in a polluted environment using 20 21 passive sampling.
    [Show full text]
  • The Breakdown of Pyruvate by Cell-Free Extracts of the Rumen Micro-Organism LC
    Vol. 74 METABOLISM OF XANTHURENIC ACID 525 with acid; no direct proof, however, is given that that the hydroxyl group in position 8 is bound to this transformation is brought about by detach- glucuronic acid. ment of a glucuronic residue from the hydroxyl group in position 4 of xanthurenic acid. The fact The authors are grateful to Professor Benassi of the that the R. values of Rothstein & Greenberg's Institute of Pharmaceutical Chemistry of the University of compounds B and D in butanol-acetic acid-water Padova for a kind gift of a sample of 8-methylxanthurenic (4:1:5) differ from those of our compounds indicate acid ethyl ester. that they are not the same substances. The differ- REFERENCES ence might tentatively be ascribed to the fact that xanthurenic acid can be conjugated in the living Baglioni, C., Fasella, P., Turano, C. & Siliprandi, N. (1960). organism in several ways and that differences exist G. Biochim. (in the Press). not only between various species, e.g. the rabbit Block, R. J. & Boiling, D. (1951). The Aminoacid Compo8i- and the rat (Rothstein & Greenberg, 1957), but tion of Protein and Foods, p. 413. Springfield, Mass.: also between different races of the same C. Thomas. species. Consden, R., Gordon, A. H. & Martin, A. J. P. (1944). Biochem. J. 38, 224. SUMMARY Dalglesh, C. E. (1952). Biochem. J. 52, 3. Dalgliesh, C. E. (1955). J. clin. Path. 8, 73. 1. Two major metabolites of xanthurenic acid Daigliesh, C. E. (1956). Biochem. J. 64, 481. were found in the urine of albino rats after intra- Dent, C.
    [Show full text]
  • 1997-11-12 Carbon Disulfide As Federal Hazardous Air Pollutant
    CARBON DISULFIDE Carbon disulfide is a federal hazardous air pollutant and was identified as a toxic air contaminant in April 1993 under AB 2728. CAS Registry Number: 75-15-0 CS2 Molecular Formula: CS2 Carbon disulfide is a highly refractive, mobile, and very flammable liquid. The purest distillates have a sweet odor. However, the usual commercial and reagent grades of carbon disulfide are foul smelling. It burns with a blue flame to form carbon dioxide and sulfur dioxide. Liquid carbon disulfide will attack some forms of plastics, rubber, and coatings but is non- corrosive to most commercial structural materials at ordinary temperatures. It is miscible in water, alcohol, oils, chloroform, and ether (Merck, 1989). Physical Properties of Carbon Disulfide Synonyms: carbon bisulfide; carbon disulphide; carbon sulfide; sulphocarbonic anhydride; sulphuret of carbon; dithiocarbonic anhydride Molecular Weight: 76.14 Boiling Point: 46.5 oC Melting Point: -111.5 oC Vapor Density: 2.67 (air =1) Flash Point: -30 oC (closed cup) Density/Specific Gravity: 1.2632 at 20/4 oC (water = 1) Critical Temperature: 280 oC Vapor Pressure: 297 mm Hg at 20 oC Log Octanol/Water Partition Coefficient: 1.70 - 4.16 Conversion Factor: 1 ppm = 3.11 mg/m3 (Howard, 1990; HSDB, 1991; Merck, 1989; U.S. EPA, 1994a) SOURCES AND EMISSIONS A. Sources Carbon disulfide is used in the preparation of rayon viscose fibers, and as a solvent for lipids, phosphorus, sulfur, selenium, bromine, iodine, rubber, resins, and waxes (Proctor et al, 1991). Carbon disulfide is also used in the manufacture of carbon tetrachloride, cellophane, flotation Toxic Air Contaminant Identification List Summaries - ARB/SSD/SES September 1997 193 Carbon Disulfide agents, xanthogenates, and numerous other chemicals (HSDB, 1991; Sax, 1987).
    [Show full text]
  • Neurotransmitters-Sample-Report
    Neurotransmitters Test the messengers of your neural network 1(866) 364-0963 www.vibrant-wellness.com 1360 Bayport Ave. Ste. B [email protected] San Carlos, CA 94070 Neurotransmitters Vibrant Wellness | 1360 Bayport Ave, Ste B. San Carlos, CA 94070 1(866) 364-0963 | [email protected] | www. vibrant-wellness.com Final Report Date: 06-19-2020 16:03 Specimen Collected: 06-18-2020 16:03 Accession ID: 2006190275 Specimen Received: 06-19-2020 10:03 LAST NAME FIRST NAME GENDER DATE OF BIRTH ACCESSION ID DATE OF SERVICE PATIENT TEST2 MALE 1998-01-06 2006190275 06-18-2020 16:03 PATIENT PROVIDER Name: TEST2 PATIENT Practice Name: Vibrant IT4 Practice Date of Birth: 1998-01-06 Provider Name: Demo Client, DDD (999994) Gender: Male Street Address: TEST STREET Age: 22 City: TEST CITY State: KY Fasting: FASTING Zip #: 42437 Telephone #: Fax #: 000-000-0000 Vibrant Wellness is pleased to present to you, 'Neurotransmitters', to help you make healthy lifestyle, dietary and treatment choices in consultation with your healthcare provider. It is intended to be used as a tool to encourage a general state of health and well-being. The Vibrant Neurotransmitters is a test to measure inhibitory, excitatory and other neurotransmitters . The panel is designed to give a complete picture of an individual’s levels of neurotransmitters in urine. Interpretation of Report: The report contains the complete list of the all urine neurotransmitters tested with quantitative results to enable a full overview along with the corresponding reference ranges. The classification of Red indicates a result that is outside the reference range and the classification of Green denotes a result that is within the reference range.
    [Show full text]
  • Carbonyl Sulfide, Dimethyl Sulfide and Carbon Disulfide In
    Atmospheric Environment 44 (2010) 3805e3813 Contents lists available at ScienceDirect Atmospheric Environment journal homepage: www.elsevier.com/locate/atmosenv Carbonyl sulfide, dimethyl sulfide and carbon disulfide in the Pearl River Delta of southern China: Impact of anthropogenic and biogenic sources H. Guo a,*, I.J. Simpson b, A.J. Ding c,T.Wanga, S.M. Saunders d, T.J. Wang c, H.R. Cheng a, B. Barletta b, S. Meinardi b, D.R. Blake b, F.S. Rowland b a Department of Civil and Structural Engineering, Hong Kong Polytechnic University, Hong Kong b Department of Chemistry, University of California at Irvine, Irvine, USA c School of Atmospheric Sciences, Nanjing University, China d School of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia, Perth, Australia article info abstract Article history: Reduced sulfur compounds (RSCs) such as carbonyl sulfide (OCS), dimethyl sulfide (DMS) and carbon Received 28 October 2009 disulfide (CS2) impact radiative forcing, ozone depletion, and acid rain. Although Asia is a large source of Received in revised form these compounds, until now a long-term study of their emission patterns has not been carried out. Here 19 June 2010 we analyze 16 months of RSC data measured at a polluted rural/coastal site in the greater Pearl River Accepted 22 June 2010 Delta (PRD) of southern China. A total of 188 canister air samples were collected from August 2001 to December 2002. The OCS and CS2 mixing ratios within these samples were higher in autumn/winter and Keywords: lower in summer due to the influence of Asian monsoon circulations.
    [Show full text]
  • Kynurenine and Tetrahydrobiopterin Pathways Crosstalk in Pain Hypersensitivity
    fnins-14-00620 June 27, 2020 Time: 15:13 # 1 REVIEW published: 24 June 2020 doi: 10.3389/fnins.2020.00620 Kynurenine and Tetrahydrobiopterin Pathways Crosstalk in Pain Hypersensitivity Ananda Staats Pires1,2, Vanessa X. Tan1, Benjamin Heng1, Gilles J. Guillemin1* and Alexandra Latini2* 1 Neuroinflammation Group, Department of Biomedical Sciences, Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia, 2 Laboratório de Bioenergética e Estresse Oxidativo, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil Despite the identification of molecular mechanisms associated with pain persistence, no Edited by: significant therapeutic improvements have been made. Advances in the understanding Marianthi Papakosta, of the molecular mechanisms that induce pain hypersensitivity will allow the Takeda Pharmaceutical Company Limited, United States development of novel, effective, and safe therapies for chronic pain. Various pro- Reviewed by: inflammatory cytokines are known to be increased during chronic pain, leading Wladyslaw-Lason, to sustained inflammation in the peripheral and central nervous systems. The Institute of Pharmacology (PAS), Poland pro-inflammatory environment activates additional metabolic routes, including the Ewa Krystyna kynurenine (KYN) and tetrahydrobiopterin (BH4) pathways, which generate bioactive Szczepanska-Sadowska, soluble metabolites with the potential to modulate neuropathic and inflammatory pain Medical University of Warsaw, Poland sensitivity. Inflammation-induced upregulation of indoleamine 2,3-dioxygenase 1 (IDO1) *Correspondence: Gilles J. Guillemin and guanosine triphosphate cyclohydrolase I (GTPCH), both rate-limiting enzymes [email protected] of KYN and BH4 biosynthesis, respectively, have been identified in experimental Alexandra Latini [email protected] chronic pain models as well in biological samples from patients affected by chronic pain.
    [Show full text]
  • Nutritional and Herbal Therapies for Children and Adolescents
    Nutritional and Herbal Therapies for Children and Adolescents A Handbook for Mental Health Clinicians Nutritional and Herbal Therapies for Children and Adolescents A Handbook for Mental Health Clinicians George M. Kapalka Associate Professor, Monmouth University West Long Branch, NJ and Director, Center for Behavior Modifi cation Brick, NJ AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 32 Jamestown Road, London NW1 7BY, UK 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA 525 B Street, Suite 1900, San Diego, CA 92101-4495, USA Copyright © 2010 Elsevier Inc. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (44) (0) 1865 843830; fax (44) (0) 1865 853333; email: [email protected]. Alternatively, visit the Science and Technology Books website at www.elsevierdirect.com/rights for further information Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material
    [Show full text]
  • Metabolic Enzyme/Protease
    Inhibitors, Agonists, Screening Libraries www.MedChemExpress.com Metabolic Enzyme/Protease Metabolic pathways are enzyme-mediated biochemical reactions that lead to biosynthesis (anabolism) or breakdown (catabolism) of natural product small molecules within a cell or tissue. In each pathway, enzymes catalyze the conversion of substrates into structurally similar products. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation. Metabolism maintains the living state of the cells and the organism. Proteases are used throughout an organism for various metabolic processes. Proteases control a great variety of physiological processes that are critical for life, including the immune response, cell cycle, cell death, wound healing, food digestion, and protein and organelle recycling. On the basis of the type of the key amino acid in the active site of the protease and the mechanism of peptide bond cleavage, proteases can be classified into six groups: cysteine, serine, threonine, glutamic acid, aspartate proteases, as well as matrix metalloproteases. Proteases can not only activate proteins such as cytokines, or inactivate them such as numerous repair proteins during apoptosis, but also expose cryptic sites, such as occurs with β-secretase during amyloid precursor protein processing, shed various transmembrane proteins such as occurs with metalloproteases and cysteine proteases, or convert receptor agonists into antagonists and vice versa such as chemokine conversions carried out by metalloproteases, dipeptidyl peptidase IV and some cathepsins. In addition to the catalytic domains, a great number of proteases contain numerous additional domains or modules that substantially increase the complexity of their functions.
    [Show full text]
  • Structural Modification of Xanthate Collectors to Enhance the Flotation
    Article pubs.acs.org/IECR Structural Modification of Xanthate Collectors To Enhance the Flotation Selectivity of Chalcopyrite † ‡ † † † Xin Ma, Liuyin Xia, Shuai Wang,*, Hong Zhong,*, and Hui Jia † College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, People’s Republic of China ‡ Surface Science, University of Western Ontario, London, Ontario N6G0J3, Canada *S Supporting Information ABSTRACT: A modified xanthate compound similar to xanthogen formates, S-benzoyl O-isobutyl xanthate (BIBX), was designed by introducing a carbonyl and a benzyl group into the xanthate structure. The preparation, recovery performance, and mechanism of adsorption of this compound to chalcopyrite is discussed. BIBX was synthesized using a one-pot approach with superior efficiency, which has important commercial implications. BIBX’s performance in the recovery of and mechanism of adsorption to chalcopyrite was investigated via flotation tests, adsorption quantity measurements, FTIR spectroscopy, X- ray photoelectron spectroscopy (XPS), and density functional theory (DFT) calculations. The results show that BIBX displays a substantially stronger collecting ability toward chalcopyrite than sodium isobutyl xanthate and O-isopropyl-N- ethylthionocarbamate. Moreover, BIBX displays superior selectivity for chalcopyrite compared to pyrite. The adsorption data indicate that BIBX can be applied under slightly acidic or alkaline conditions. BIBX behaves like a bidentate ligand, bonding with the chalcopyrite copper through the thiol sulfur and carbonyl oxygen atoms. These findings are supported by FTIR and XPS data. DFT calculations predict two distinct adsorption geometries, one with one Cu atom to form a six-membered ring complex and another with two Cu atoms to form an “irregular pentagon”-shaped complex. 1. INTRODUCTION atom.
    [Show full text]